CMPX Hisse Senedi Fiyat Grafiği
CMPX Kazanmak
Compass Therapeutics Inc.
$1.84
2.79%
$0.05
Kapanışta: Apr 28, 16:00:00 GMT-4
$1.88
2.69%
$0.04
Ön Piyasa: Apr 29, 05:30:21 GMT-4
Geri
Compass Therapeutics Inc. (CMPX) Kazanmak
Önemli İstatistikler
Önceki Kapanış
$1.79
Açılış fiyatı
$1.91
Günün Aralığı
$1.79 - $2.18
52 haftalık aralık
$1.66 - $6.88
İşlem hacmi
37.2M
Ort.Hacim
2.3M
Dividend yield
--
EPS (TTM)
-0.31
Piyasa Değeri
$340.2M
CMPX nedir?
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. The company is headquartered in Boston, Massachusetts and currently employs 39 full-time employees. The company went IPO on 2020-11-13. The firm is developing proprietary antibody-based therapeutics to treat multiple human diseases. Its pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. Its lead product candidate, tovecimig, is a bispecific antibody targeting Delta-like ligand 4 (DLL4), a ligand of Notch-1, and vascular endothelial growth factor A (VEGF-A). Its second program, CTX-471, is an agonistic antibody targeting a member of the tumor necrosis factor receptor superfamily member 9 (TNFRSF9), also known as CD-137, a co-stimulatory receptor which is mostly expressed on activated, but not on resting T-cells and NK cells. Its third program, CTX-8371, is a bispecific antibody targeting the programmed cell death protein-1 (PD-1), an inhibitory immune checkpoint receptor, and its ligand PD-L1, two validated immune-oncology targets.
